Form 4 for ISRG Intuitive Surgical
Accepted 2025-05-01 00:00:00 ET · period of report 2025-04-30 · accession 0001035267-25-000137 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-05-01 | 2025-04-30 | ISRG | Ladd Amy L | Dir | S - Sale+OE | $505.55 | -8,776 | 1,410 | -86% | -$4.44M |
| DM | 2025-05-01 | 2025-04-30 | ISRG | Ladd Amy L | Dir | M - OptEx | $229.31 | +8,776 | 3,060 | New | +$2.01M |
| DM | 2025-05-01 | 2025-04-30 | ISRG | Ladd Amy L | Dir | M - OptEx | $0.00 | -8,776 | 0 | -100% | $0 |
| D | 2025-05-01 | 2025-05-01 | ISRG | Ladd Amy L | Dir | A - Grant | $0.00 | +531 | 531 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-30 | S | D | 1,671 | $505.55 | 1,410 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $502.49 to $509.99 as follows: 1,758 shares sold at $502.49 to $503.39; 1,542 shares sold at $503.81 to $504.79; 1,951 shares sold at $504.83 to $505.77; 1,845 shares sold at $505.88 to $506.53; 610 shares sold at $506.90 to $507.84; and 1,070 shares sold at $509.99. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2025-04-30 | M | A | 1,671 | $286.55 | 3,081 | D | — | — | |
| 3 | Common | Common Stock | 2025-04-30 | S | D | 1,448 | $505.55 | 1,410 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $502.49 to $509.99 as follows: 1,758 shares sold at $502.49 to $503.39; 1,542 shares sold at $503.81 to $504.79; 1,951 shares sold at $504.83 to $505.77; 1,845 shares sold at $505.88 to $506.53; 610 shares sold at $506.90 to $507.84; and 1,070 shares sold at $509.99. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2025-04-30 | M | A | 1,448 | $243.26 | 2,858 | D | — | — | |
| 5 | Common | Common Stock | 2025-04-30 | S | D | 1,709 | $505.55 | 1,410 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $502.49 to $509.99 as follows: 1,758 shares sold at $502.49 to $503.39; 1,542 shares sold at $503.81 to $504.79; 1,951 shares sold at $504.83 to $505.77; 1,845 shares sold at $505.88 to $506.53; 610 shares sold at $506.90 to $507.84; and 1,070 shares sold at $509.99. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 6 | Common | Common Stock | 2025-04-30 | M | A | 1,709 | $295.92 | 3,119 | D | — | — | |
| 7 | Common | Common Stock | 2025-04-30 | S | D | 1,650 | $505.55 | 1,410 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $502.49 to $509.99 as follows: 1,758 shares sold at $502.49 to $503.39; 1,542 shares sold at $503.81 to $504.79; 1,951 shares sold at $504.83 to $505.77; 1,845 shares sold at $505.88 to $506.53; 610 shares sold at $506.90 to $507.84; and 1,070 shares sold at $509.99. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 8 | Common | Common Stock | 2025-04-30 | M | A | 2,298 | $171.07 | 3,708 | D | — | — | |
| 9 | Common | Common Stock | 2025-04-30 | S | D | 2,298 | $505.55 | 1,410 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $502.49 to $509.99 as follows: 1,758 shares sold at $502.49 to $503.39; 1,542 shares sold at $503.81 to $504.79; 1,951 shares sold at $504.83 to $505.77; 1,845 shares sold at $505.88 to $506.53; 610 shares sold at $506.90 to $507.84; and 1,070 shares sold at $509.99. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 10 | Common | Common Stock | 2025-04-30 | M | A | 1,650 | $171.20 | 3,060 | D | — | — | |
| 11 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-04-30 | M | D | 1,709 | $0.00 | 0 | D | $295.92 · — to 2030-04-26 | 1,709 Common Stock | (F3) 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer. |
| 12 | Derivative | Restricted Stock Units | 2025-05-01 | A | A | 531 | $0.00 | 531 | D | $0.00 · — to — | 531 Common Stock | (F4) 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. |
| 13 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-04-30 | M | D | 2,298 | $0.00 | 0 | D | $171.07 · — to 2030-04-23 | 2,298 Common Stock | (F3) 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer. |
| 14 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-04-30 | M | D | 1,671 | $0.00 | 0 | D | $286.55 · — to 2031-04-22 | 1,671 Common Stock | (F3) 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer. |
| 15 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-04-30 | M | D | 1,650 | $0.00 | 0 | D | $171.20 · — to 2029-08-02 | 1,650 Common Stock | (F3) 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer. |
| 16 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-04-30 | M | D | 1,448 | $0.00 | 0 | D | $243.26 · — to 2029-04-27 | 1,448 Common Stock | (F3) 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer. |